How to reveal the invisible college and pull away from competition
How a hidden network of experts can support your strategy with directional insights.
New: 6 essential pharmaceutical industry statistics to know in 2024
What major trends and market forces point the way to pharma’s future?
5 recommendations for introducing AI in medical affairs
New tech brings new challenges, but you can prepare with these expert tips.
AI use and proficiency will increase in the year ahead
Now is the time to learn how your life science organization can leverage AI to augment human expertise.
How tech improves insights analysis and reporting in pharma
Improving insights management often begins in the middle. Here’s how technology (yes, including AI) supports faster, more accurate strategic decisions.
Why you’re missing a third of the KOLs you need
Engaging the “wrong” KOLs has consequences. Here’s why old approaches to finding expert voices don’t work as well anymore.
Mastering the insights loop: a vital process for elevating medical affairs strategies
Insights management is never really “finished.” Here’s how medical affairs teams are positioning themselves for continuous improvement.
Getting insights from allied health: 7 tips to use now
KOLs outside the traditional physician profile can offer critical insight throughout drug development and launch. Here’s how to include this group in your next ad board.
Transforming pharma: a year of top trends shaping the industry’s future
We examined a year of trend tracking to see what we could learn about where pharma is headed.
Podcast: how to improve engagement with allied health professionals
In our latest episode, an expert explains why pharma teams must include allied health professionals in their key engagements.